John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPT
2326
Rithm Property Trust
RPT
$102M
| $655K | ﹤0.01% |
38,022
+15,166
| +66% | +$274K |
|
|
DCBO
2327
Docebo
DCBO
$614M
| $651K | ﹤0.01% |
22,691
-29,773
| -57% | -$1.12M |
|
2328
IBM
IBM
$221B
| $650K | ﹤0.01% |
2,616
+135
| +5% | +$33K |
|
2329
Towne Bank
TOWN
$3.49B
| $650K | ﹤0.01% |
19,019
+892
| +5% | +$31.4K |
|
2330
Diebold Nixdorf
DBD
$2.3B
| $650K | ﹤0.01% |
14,870
| – | – |
|
2331
Ooma
OOMA
$566M
| $650K | ﹤0.01% |
49,639
-50,843
| -51% | -$720K |
|
2332
Cerence
CRNC
$363M
| $649K | ﹤0.01% |
82,176
-508,199
| -86% | -$6.25M |
|
|
FLNA
2333
Filana Therapeutics
FLNA
$45.8M
| $649K | ﹤0.01% |
432,581
-129,501
| -23% | -$327K |
|
2334
Shoals Technologies Group
SHLS
$1.16B
| $648K | ﹤0.01% |
195,328
-462,261
| -70% | -$1.92M |
|
2335
Plug Power
PLUG
$3.17B
| $648K | ﹤0.01% |
479,900
-489,427
| -50% | -$931K |
|
2336
NCR Voyix
VYX
$1.12B
| $647K | ﹤0.01% |
66,406
-115,167
| -63% | -$1.35M |
|
2337
JFrog
FROG
$11B
| $646K | ﹤0.01% |
20,200
-12,330
| -38% | -$429K |
|
2338
Viant Technology
DSP
$260M
| $643K | ﹤0.01% |
51,850
+41,484
| +400% | +$760K |
|
2339
Corbus Pharmaceuticals
CRBP
$219M
| $643K | ﹤0.01% |
121,164
-13,011
| -10% | -$115K |
|
2340
AudioCodes
AUDC
$237M
| $641K | ﹤0.01% |
68,088
-7,565
| -10% | -$80.7K |
|
2341
Calix
CALX
$2.51B
| $641K | ﹤0.01% |
18,089
-11,905
| -40% | -$442K |
|
2342
Onto Innovation
ONTO
$17.8B
| $641K | ﹤0.01% |
5,283
+3,374
| +177% | +$568K |
|
2343
CEVA Inc
CEVA
$762M
| $641K | ﹤0.01% |
25,017
-11,359
| -31% | -$365K |
|
2344
Pacific Biosciences
PACB
$472M
| $640K | ﹤0.01% |
542,200
-571,377
| -51% | -$876K |
|
|
LAC
2345
Lithium Americas
LAC
$1.18B
| $637K | ﹤0.01% |
235,157
+14,306
| +6% | +$43.1K |
|
2346
Keros Therapeutics
KROS
$232M
| $636K | ﹤0.01% |
62,372
+28,708
| +85% | +$333K |
|
2347
Shenandoah Telecom
SHEN
$680M
| $634K | ﹤0.01% |
50,408
+40,377
| +403% | +$475K |
|
2348
Church & Dwight Co
CHD
$24.3B
| $630K | ﹤0.01% |
+5,723
| New | +$613K |
|
2349
Northern Trust Quality Dividend ETF
QDF
$2.25B
| $629K | ﹤0.01% |
9,200
-24,300
| -73% | -$1.72M |
|
2350
NatWest
NWG
$74.9B
| $628K | ﹤0.01% |
52,709
-1,646
| -3% | -$18.5K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.